HRP960117B1 - Bicyclic compounds, their preparation and use in pharmaceutical preparations - Google Patents

Bicyclic compounds, their preparation and use in pharmaceutical preparations

Info

Publication number
HRP960117B1
HRP960117B1 HR960117A HRP960117A HRP960117B1 HR P960117 B1 HRP960117 B1 HR P960117B1 HR 960117 A HR960117 A HR 960117A HR P960117 A HRP960117 A HR P960117A HR P960117 B1 HRP960117 B1 HR P960117B1
Authority
HR
Croatia
Prior art keywords
preparation
pharmaceutical preparations
bicyclic compounds
bicyclic
compounds
Prior art date
Application number
HR960117A
Other languages
English (en)
Inventor
Federico Arcamone
Alberto Carlo Maggi
Laura Quartara
Danilo Giannotti
Original Assignee
Menarini Farma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11351134&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP960117(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Menarini Farma Ind filed Critical Menarini Farma Ind
Publication of HRP960117A2 publication Critical patent/HRP960117A2/hr
Publication of HRP960117B1 publication Critical patent/HRP960117B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR960117A 1995-03-13 1996-03-13 Bicyclic compounds, their preparation and use in pharmaceutical preparations HRP960117B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95FI000044A IT1277835B1 (it) 1995-03-13 1995-03-13 Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
HRP960117A2 HRP960117A2 (en) 1997-08-31
HRP960117B1 true HRP960117B1 (en) 2001-06-30

Family

ID=11351134

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960117A HRP960117B1 (en) 1995-03-13 1996-03-13 Bicyclic compounds, their preparation and use in pharmaceutical preparations

Country Status (33)

Country Link
US (1) US6150325A (es)
EP (1) EP0815126B1 (es)
JP (1) JP4618821B2 (es)
KR (1) KR100405009B1 (es)
CN (1) CN1189477C (es)
AR (1) AR004476A1 (es)
AT (1) ATE198481T1 (es)
AU (1) AU696528B2 (es)
BG (1) BG63208B1 (es)
BR (1) BR9607348A (es)
CZ (1) CZ287372B6 (es)
DE (1) DE69611438T2 (es)
DK (1) DK0815126T3 (es)
EA (1) EA000697B1 (es)
EE (1) EE03618B1 (es)
ES (1) ES2155187T3 (es)
GE (1) GEP20002271B (es)
GR (1) GR3035676T3 (es)
HR (1) HRP960117B1 (es)
HU (1) HU222051B1 (es)
IL (1) IL117395A (es)
IT (1) IT1277835B1 (es)
MX (1) MX9706927A (es)
NO (1) NO319290B1 (es)
NZ (1) NZ303982A (es)
PL (1) PL184147B1 (es)
PT (1) PT815126E (es)
RO (1) RO118297B1 (es)
SK (1) SK281899B6 (es)
TW (1) TW565572B (es)
UA (1) UA48962C2 (es)
WO (1) WO1996028467A1 (es)
ZA (1) ZA961983B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017705A (en) * 1995-03-14 2000-01-25 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof
IT1291776B1 (it) * 1997-02-07 1999-01-21 Menarini Ricerche Spa Composti monociclici a quattro residui bifunzionali, aventi azione nk-2 antagonista
IT1304888B1 (it) * 1998-08-05 2001-04-05 Menarini Ricerche Spa Composti monociclici ad azione nk-2 antagonista e formulazioni che licontengono
DE60129562T2 (de) * 2000-06-12 2008-04-17 The University Of Rochester Methode zur Behandlung von Hitzewallungen durch Verwendung eines Tachykinin-Rezeptor-Antagonisten
EP1297826A1 (en) * 2001-09-27 2003-04-02 Menarini Ricerche S.p.A. Nasal pharmaceutical compositions containing a NK-2 antagonist
ITFI20020239A1 (it) 2002-12-06 2004-06-07 Menarini Ricerche Spa Processo per la preparazione di composti peptidici biciclici.
ITFI20040221A1 (it) 2004-10-27 2005-01-27 Guidotti & C Spa Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
ITRM20120331A1 (it) 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262902B (it) * 1992-04-15 1996-07-22 Menarini Farma Ind Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.

Also Published As

Publication number Publication date
MX9706927A (es) 1997-11-29
BG63208B1 (bg) 2001-06-29
EP0815126A1 (en) 1998-01-07
GR3035676T3 (en) 2001-06-29
ZA961983B (en) 1997-09-29
IT1277835B1 (it) 1997-11-12
PT815126E (pt) 2001-06-29
NO319290B1 (no) 2005-07-11
ITFI950044A1 (it) 1996-09-13
KR100405009B1 (ko) 2004-05-20
HRP960117A2 (en) 1997-08-31
CN1183786A (zh) 1998-06-03
IL117395A0 (en) 1996-07-23
ATE198481T1 (de) 2001-01-15
AR004476A1 (es) 1998-12-16
DE69611438D1 (de) 2001-02-08
IL117395A (en) 1999-12-31
AU696528B2 (en) 1998-09-10
CZ287372B6 (en) 2000-11-15
BG101849A (en) 1998-04-30
TW565572B (en) 2003-12-11
GEP20002271B (en) 2000-10-25
DK0815126T3 (da) 2001-05-07
EP0815126B1 (en) 2001-01-03
ITFI950044A0 (it) 1995-03-13
SK121297A3 (en) 1998-02-04
JP4618821B2 (ja) 2011-01-26
CN1189477C (zh) 2005-02-16
DE69611438T2 (de) 2001-06-13
HUP9801835A2 (hu) 1999-01-28
UA48962C2 (uk) 2002-09-16
HUP9801835A3 (en) 2000-05-29
WO1996028467A1 (en) 1996-09-19
EA199700223A1 (ru) 1998-04-30
ES2155187T3 (es) 2001-05-01
SK281899B6 (sk) 2001-09-11
HU222051B1 (hu) 2003-04-28
KR19980703011A (ko) 1998-09-05
PL322105A1 (en) 1998-01-05
NZ303982A (en) 1998-04-27
NO974057D0 (no) 1997-09-03
EA000697B1 (ru) 2000-02-28
NO974057L (no) 1997-11-07
PL184147B1 (pl) 2002-09-30
CZ286297A3 (cs) 1998-02-18
EE03618B1 (et) 2002-02-15
JPH11501643A (ja) 1999-02-09
US6150325A (en) 2000-11-21
EE9700230A (et) 1998-04-15
BR9607348A (pt) 1997-12-30
RO118297B1 (ro) 2003-04-30
AU5105996A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
EG24144A (en) Disubstituted bicyclic heterocycles their preparation and their use as medicaments
IL139235A0 (en) Pharmaceutical preparations
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL127132A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
EP0830357A4 (en) RADIOSENSITIZING DIAMINES AND PHARMACEUTICAL PREPARATIONS THEREOF
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
AU5650894A (en) Tachyquinine antagonists, their preparation and use in pharmaceutical formulations
HRP960117B1 (en) Bicyclic compounds, their preparation and use in pharmaceutical preparations
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
IL164513A0 (en) Pyrazolopyrimidines, pharmaceutical compositions containing them, and their use in the preparation of medicaments
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL116658A0 (en) Peptides their preparation and use
AP9801196A0 (en) Pharmaceutical preparation
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
AUPM855194A0 (en) Controlled-release pharmaceutical preparations
HUP9602220A3 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
GB9302553D0 (en) Pharmaceutical preparations and their manufacture and use

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20150202

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20160313